company background image
531146 logo

Medicamen Biotech BSE:531146 Stock Report

Last Price

₹459.10

Market Cap

₹5.8b

7D

-6.7%

1Y

-15.2%

Updated

30 Jan, 2025

Data

Company Financials

Medicamen Biotech Limited

BSE:531146 Stock Report

Market Cap: ₹5.8b

531146 Stock Overview

A pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. More details

531146 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance1/6
Financial Health4/6
Dividends1/6

Risk Analysis

Earnings have declined by 3% per year over past 5 years

Profit margins (4.2%) are lower than last year (8.4%)

Does not have a meaningful market cap (₹6B)

Volatile share price over the past 3 months compared to the Indian market


My Notes

Capture your thoughts, links and company narrative

Medicamen Biotech Limited Competitors

Vikram Thermo (India)

BSE:530477

₹6.6b

Kilitch Drugs (India)

BSE:524500

₹5.0b

Kerala Ayurveda

BSE:530163

₹5.1b

Sakar Healthcare

NSEI:SAKAR

₹6.0b

Price History & Performance

Summary of share price highs, lows and changes for Medicamen Biotech
Historical stock prices
Current Share Price₹459.10
52 Week High₹630.00
52 Week Low₹356.75
Beta1.53
1 Month Change-10.14%
3 Month Change-16.97%
1 Year Change-15.22%
3 Year Change-44.99%
5 Year Change34.59%
Change since IPO3,167.62%

Recent News & Updates

Recent updates

Shareholder Returns

531146IN PharmaceuticalsIN Market
7D-6.7%-4.0%-1.8%
1Y-15.2%20.3%6.2%

Return vs Industry: 531146 underperformed the Indian Pharmaceuticals industry which returned 18.6% over the past year.

Return vs Market: 531146 underperformed the Indian Market which returned 5.8% over the past year.

Price Volatility

Is 531146's price volatile compared to industry and market?
531146 volatility
531146 Average Weekly Movement7.6%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 531146's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 531146's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
1993378Rajesh Madanwww.medicamen.com

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarial, vitamins and supplements, other generics, and pain management.

Medicamen Biotech Limited Fundamentals Summary

How do Medicamen Biotech's earnings and revenue compare to its market cap?
531146 fundamental statistics
Market cap₹5.84b
Earnings (TTM)₹75.63m
Revenue (TTM)₹1.82b

77.2x

P/E Ratio

3.2x

P/S Ratio

Is 531146 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
531146 income statement (TTM)
Revenue₹1.82b
Cost of Revenue₹986.19m
Gross Profit₹829.95m
Other Expenses₹754.32m
Earnings₹75.63m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.95
Gross Margin45.70%
Net Profit Margin4.16%
Debt/Equity Ratio9.3%

How did 531146 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

19%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 08:50
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medicamen Biotech Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research